Medscape Oncology

Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.

[Medscape Oncology @MedscapeOnc]

🧠 Real questions. Real answers. Real impact. 💥 Join a high-impact forum covering HR+, HER2+, and triple-negative breast cancer—designed for clinicians who want practical, usable insights. 🎙️ Ask experts, challenge thinking, and leave with strategies you can apply immediately. 📌 https://t.co/pnzGF0u4ms

#PBCClive26

[Medscape Oncology @MedscapeOnc]

What’s new in mCRC care? 🧬

Join our 15-min live stream with Dr. Pietrantonio & Dr. Oberstein to break down new data and regimens to overcome EGFR inhibitor resistance.

📅 June 19th
⏰ 3:30pm ET
🔗 https://t.co/QnbQCPYVv1

#Oncology #CME

[Medscape Oncology @MedscapeOnc]

How are the latest target therapies shifting the way you approach the early stages of IDH-mutant glioma management?

Come explore the new era of glioma management with us, and dive into expert strategies for timing therapies just right and tailoring your approach to each unique patient.

Read here: https://t.co/G5sV3icRH7

[Medscape Oncology @MedscapeOnc]

The Blueprint for Modern mHSPC Care https://t.co/VLVhBmGpVo

[Medscape Oncology @MedscapeOnc]

Starting in 1 HOUR ➡️ https://t.co/rBfJtR5cQs

Don't miss our live stream with Dr. Alicia Morgans! Get up to speed on the latest 2026 mHSPC data and join the real-time Q&A on treatment intensification with ARPIs. See you there!

#mHSPC #ProstateCancer #Oncology

[Medscape Oncology @MedscapeOnc]

💡 What are experts doing differently right now in breast cancer care?
Get inside the decision-making, not just the data.

👉 See what’s changing: https://t.co/mTs8YQOa9b

#PBCClive26

[Medscape Oncology @MedscapeOnc]

How have newer targeted therapies shifted how you use radiation in daily glioma management?

Explore the foundational role of radiation oncology today and get actionable tips to optimize treatment timing and outcomes.

Read here:: https://t.co/J9woV4wofh

[Medscape Oncology @MedscapeOnc]

LIVE TOMORROW ➡️ The Blueprint for Modern mHSPC Care.

Bring your questions as Dr. Alicia Morgans breaks down the key abstracts in mHSPC presented so far in 2026, with a focus on treatment intensification with androgen receptor pathway inhibitors (ARPIs).

📅 June 12th
⏰ 10:30am EST
🔗 https://t.co/ZNKQS2JrUc

#mHSPC #Oncology #CME

[Medscape Oncology @MedscapeOnc]

🔬 Treating pediatric cancer is only step one
🦴 Understand long-term skeletal implications of TRK inhibitors
🧩 Align care teams to optimize decisions
📈 Design survivorship plans for lifelong outcomes
🔥 Unlock: https://t.co/2Xs8De3aJ5

[Medscape Oncology @MedscapeOnc]

Monotherapy is rapidly being relegated to the past.

Learn why early combination protocols are non-negotiable to delay progression to castration resistance and maximize patient survival.

Catch up on the latest data ➡️ https://t.co/WlguAjoEwP

#Oncology #MedEd #CME

[Medscape Oncology @MedscapeOnc]

SAVE THE DATE 🗓️

Got 15 mins? Join Dr. Filippo Pietrantonio & Dr. Paul Oberstein to tackle EGFR inhibitor resistance and data for novel regimens to overcome it.

📅 June 19th
⏰ 3:30pm ET
🔗 https://t.co/QnbQCPYVv1

#Oncology #CME

[Medscape Oncology @MedscapeOnc]

🎬 Catch the highlights from #ALFlive26 and see why everyone’s still talking about it! More innovation, more education, and even bigger things are coming for #ALFlive27 🚀
🔗 https://t.co/bBWRBhsx9k

[Medscape Oncology @MedscapeOnc]

With lung cancer research moving faster than ever, what is your biggest challenge when trying to keep up with new data for ALK-positive and small-cell lung cancers?

Join us to explore breaking developments and emerging science in ALK-positive NSCLC and ES-SCLC, and discover practical ways to bring these cutting-edge advancements straight to your clinic.

Read here: https://t.co/fwSYvw6BEH

[Medscape Oncology @MedscapeOnc]

🧪 Don't miss @breastoncdoc and join Perspectives in Breast Cancer Care to explore emerging evidence and evolving oncology strategies. 📚 https://t.co/fFlADPuW5G
#PBCClive26

[Medscape Oncology @MedscapeOnc]

How are we integrating AI into #Hematology and #Oncology?

Join us for our upcoming #EHA2026 hybrid symposium - Future-Ready Hematologists: Practical & Ethical Use of AI.

Hear insights directly from Chan Cheah (featured in this clip), Jakob N. Kather and Matthew Lunning as they discuss cutting through the hype to find practical, ethical ways AI can support clinical decision-making.

📅 Thursday, 11 June 2026 | 08:00 - 09:30 CEST
📍 Stockholmsmässan, Room: A2-3 Hall
👀 Register for the hybrid session here: https://t.co/OhN7eGrSno

#EHA2026 #Hematology #Oncology #AIinMedicine #Medscape

[Medscape Oncology @MedscapeOnc]

📊 Knowledge is everywhere—practical application isn’t. Get clear, actionable strategies across HR+, HER2+, and TNBC you can use immediately.

👉 Walk away with answers 🔗 https://t.co/mTs8YQOa9b

#PBCClive26

[Medscape Oncology @MedscapeOnc]

How is AI shaping the future of hematology and oncology?

As AI rapidly integrates into clinical practice, understanding both its practical applications and ethical implications is crucial.

Join Medscape Oncology for a hybrid symposium at #EHA2026 to explore how to become a "future-ready" hematologist.

📅 When: Thursday, 11 June 2026 | 08:00 – 09:30 CEST 📷 Where: Stockholmsmässan, Room: A2-3 Hall or register to join online here: https://t.co/OhN7eGrSno

#EHA #Medscape #Hematology #Oncology #AI

[Medscape Oncology @MedscapeOnc]

What's new in modern mHSPC care?

Join our live event with Dr. Alicia Morgans to review key 2026 oncology & urology abstracts. Submit your questions live during the Q&A!

📅 June 12th
⏰ 10:30am EST
🔗 https://t.co/rBfJtR5cQs

#ProstateCancer #Oncology #CME

[Medscape Oncology @MedscapeOnc]

Heading to Stockholm for #EHA2026?

The Medscape team is looking forward to connecting with the global hematology community.

Stop by Booth C1.02 from June 11-14 to meet our team and explore our latest resources. Be sure to ask us about Medscape AI and how we are leveraging next-generation technology to support clinical decision-making and innovation in hematology.

See you there!

#Medscape #EHA #Oncology

[Medscape Oncology @MedscapeOnc]

Early treatment intensification is a game-changer in mHSPC.

Watch as experts explain why missing the early treatment window means patients can't make up the lost survival benefit later.

Watch the full episode ➡️ https://t.co/WlguAjoEwP

#Oncology #MedEd #CME